It has now been established that the LCPUFA DHA [C22:6(n-3)] and AA [C20:4(n-6)] should be supplied in formula milks fed to both term and preterm infants (1-5). What is uncertain, however, is the optimum duration for such supplementation. To estimate this would probably require us to define the age at which DHA and AA are synthesized in the infant liver by enzymatic conversion of their essential fatty acid precursors a-linolenic [C18:3(n-3)] and linoleic acid [Cl8:2(n-6)], respectively. Desaturation of these essential fatty acids is performed in a series of reactions located primarily in the hepatic rnicrosornes of the endoplasrnic reticulum. Conversion of a-linolenic acid to DHA and linoleic acid to AA proceeds via successive desaturation and elongation reactions involving A6-and A5-desaturase enzymes and A4-desaturation, with in vitro studies initially implicating A6-desaturase as the ratelimiting step (6). Measurement of the A6-and AS-desaturases has been made in human tissue (7, 8) , although most research the human milk-fed group. The age-related distributions of docosahexaenoic acid showed that coincident minimuln levels were present in both formula groups in the third month of life. This may indicate that the hepatic enzymes involved in the final stage (A4-desaturation) conversion of a-linolenic acid to docosahexaenoic acid could be inactive in the first months of life. Emphasis must be on provision of preformed dietary docosahexaenoic acid and possibly arachidonic acid as well as their essential fatty acid precursors, to both term and preterm infants for at least the first 16 wk of life. (Pediatr Res 38: 361-365, 1!)95) Abbreviations DHA, docosahexaenoic acid AA, arachidonic acid LCPUFA, long-chain polyunsaturated fatty acid in this area has inevitably been confined to animal models (9) (10) (11) (12) . We considered that as the complex multistage enzyme systems involved are unstable and rapidly inactivated in biopsy material (7) , analysis of the hepatic LCPUFA products of these reactions might be more informative as to their overall in vivo activities (13, 14) . In the rat administered radiolabeled linoleic and a-linolenic acids have been subsequently identified in liver triglyceride and phospholipid fractions as both the parent and LCPUFA derivative (15) . Any investigation of liver fatty acids would therefore need to take into account this widespread distribution of LCPUFA. However, n o in viiro enzymatic assays will ever adequately represent the complexity of lipid interactions associated with the intact liver. The most recently published results for human neonatal hepatic microsomal desaturases (7) appear to indicate enzyme activities of an order that may be sufficient to provide a limited supply of both DHA and AA to neuronal tissue to enable repair and renewal but inadequate for the large amounts of these LCPUFA required by the rapidly growing brain during this early period of development (2, 16, 17) . In addition, as the hepatic desaturase activities are known to be dependent on initial substrate concentrations, we recognized that examination of tissue from infants having FARQUHARSON ET AL. received a diet low in a-linolenic acid may be particularly 18% of total fatty acids. Liver tissue from two preterm infants informative.
(30 and 32 wk of gestation) aged 10 and 17 wk, respectively, fed diet 2 and a further two 13-wk-old preterm infants (31 and METHODS 33 wk of gestation) fed diet 3 were examined.
The population investigated were infants diagnosed as sudden infant death syndrome by experienced pediatric pathologists. They were aged less than 6 mo and had lived in the Greater Glasgow Health Board area during the period of 6 y from May 1987 to July 1993. Liver specimens were taken at necropsy from the right lobe and stored at -60°C before analysis. Pathologic examination excluded any specimens in which significant fatty infiltration or deposition had been evident. Liver samples from 27 term infants were subsequently assigned to one of three feeding groups, the prerequisite of which being that the infant had received exclusively a milk diet of fatty acid composition defined by that group. The ageequivalent dietary group compositions and details are provided in Table 1 . Group 1 infants were breast fed, receiving both LCPUFA and their essential fatty acid precursors. Group 2 were fed exclusively SMA formula devoid of LCPUFA (C20 and C22) but with an a-linolenic acid content of 1.5% of total fatty acids, a composition similar to that found in most U.S. and European formulations. Group 3 infants had been fed formulas both lacking in these LCPUFA but also with low concentrations of a-linolenic acid varying between <0.1% and 0.4% of total fatty acids, which were unique to the milks outlined in Table 1 . In spite of the extended collection period, few significant changes occurred in the lipid contents of the Tissue analysis. On thawing, core samples (250-500 rng) were taken from the liver, and extraneous blood was removed by washing with distilled water. On drying, the tissue was weighed, lipid extraction was performed as previously described (I), and the weight of lipid isolated was noted to calculate the percentage of recovery. Fatty acids were derivatized in 2-mL boron trifluoride:methanol (14% wtlvol) to which 200 FL of chloroform had been added, enabling the phospholipids, triglycerides, and cholesterol esters to be transesterified in a one-step procedure to give fatty acid extracts of total hepatic lipid. The derivatized fatty acid methyl esters were separated and identified by gas chromatography (1).
To correct for the non-fatty acid component of these lipids toward recoveries, extracts were assayed for total cholesterol (cholesterol 352-20, Sigma Chemical Co., UK), triglyceride glycerol (triglyceride UV, 334-A, Sigma Chemical Co., UK) and phospholipid choline phosphate (18) . To verify homogeneous distribution of liver fatty acids tissue samples were assayed from two different parts of each specimen. The assessment of stability of hepatic fatty acids with storage of tissue at -60°C was evaluated by reassaying specimens after intervals of between 6 mo and 1 y.
STATISTICAL ANALYSIS
formula milks in respect of the nonessential saturated and
The 10 most abundant fatty acids accounted for >98% of mono-unsaturated fatty acids. During this time formula linoleic total lipid fatty acids (Table 2) . Results were expressed, with acid contents remained relatively constant at between 12 to reference to lipid recovery, as glkg wet tissue. In all groups both M and DHA exhibited age-dependent results' distributions, which were subjected to regression analysis and optimal curve fit (dependent on identifiable maxima and minima), computed by the Cricket Graph program (Computer Associates, San Diego, CA). The derived second (group 1) and third (groups 2 and 3) degree polynomials and calculated coefficients of determination (2) are shown ( Figs. 1 and 2 ).
The essential and nonessential fatty acid contents did not display a similar covariation with age (Minitab 10, Minitab Inc., PA) and were not normally distributed. Their group differences were therefore analyzed by the nonparametric, two-tailed Mann-Whitney U test with significance levels set at The small number of observations (n := 4) on preterm infants and their absence from the breast-fed group precluded between group statistical analysis; however, visual interpretation of their LCPUFA results with respect to the corresponding term individuals was made.
RESULTS
The results of the hepatic total lipid fatty acid analyses are best subdivided into three categories, namely the nonessential (saturated and mono-unsaturated), the essential (linoleic and a-linolenic), and their LCPUFA derivatives. There were no significant differences between feeding groups in the nonessential fatty acids ( Table 2 ). The hepatic essential fatty acid, a-linolenic, content was significantly lower in group 3 than in both groups 1 (p < 0.01) and 2 (p < 0.8002). In general, human milk-fed infants had greater concentrations of the LCPUFA AA and DHA than those fed either of the formula diets, with results' ranges ( Table 2 ) and distributions illustrated (Figs. 1  and 2 ). Hepatic AA content in group 1 nevertheless fell gradually over the 5-mo period from 4 t:o 3 g/kg tissue (Fig. 1) . Polynomial equations demonstrated that both formula groups had minimal liver AA content (2 g/kg tissue) in the third month of life (8-10 wk) with a subsequent rapid increase. The curves for groups 1 and 2 intersected at 16 wlc and those of groups 1 and 3 became tangential at approximately 18 wk before again diverging. In comparison with breast-fed infant liver the reduction in absolute amounts of M in the liver of formula-fed infants throughout the first months of life was on average approximately 1 g/kg tissue or approximately 0.15-0.20 g AA per liver. No obvious differences were evident in AA concentrations between term and preterm infants of similar chronologic age.
with C20:4(n-6) contents in g/kg wet tissue and x in weeks. e, Group 1; A, Although the pattern of results for hepatic DHA (Fig. 2) groups 2 and 3 again coincident during the third month, the major differences were that the human milk fed compositions were more randomly distributed, and in group 3 no increase in liver DHA concentrations was detected at the end of the third month such that the reduction with respect to the group 1 infants at 21 wk was still of the order of 1 g/kg tissue (Fig. 2) . In group 2 an increase in DHA levels in the older infants ( > I 2 wk) was apparent (Fig. 2) but they did not impinge on the group 1 curve at any stage. The hepatic DHA compositions of the preterm infants were not substantially different from their term counterparts, although there was no evidence of an increase in DHA in the 17-wk-old infant of 32 wk of gestation. No significant differences were found between the results of the duplicate tissue analyses nor in those reassayed after long-term (up to 12 mo) storage.
DISCUSSION
At first sight it may seem impossible to unravel and evaluate the many individual contributions toward hepatic fatty acid concentrations in early life. To reduce the complications in such a process we sought to ensure that our experimental procedures would estimate total fatty acids derived from the three major lipid components, the phospholipids, triglycerides, and cholesterol esters. Hepatic metabolism of these fatty acids involves several cell organelles, initially mitochondria1 synthesis from malonyl and acetyl CoA or breakdown by P-oxidation predominantly confined to the nonessential saturated and mono-unsaturated fatty acids and specific for those up to a 16-carbon chain length (palmitic acid).
From Tables 1 and 2 , it can be seen that there is a degree of correlation between the levels of hepatic and dietary nonessential fatty acids. Similarly it was probably to be expected that the essential fatty acids, linoleic and a-linolenic, would reflect dietary intake (Table 2) ; however, although they themselves contribute little to neuronal structures (19, 20) , they are of critical importance as substrates in the hepatic synthesis of the LCPUFA AA and DHA, respectively. Formerly thought to be restricted to the microsomes, new evidence suggests that synthesis of DHA also has a peroxisomal component (21) . Some evaluation of the individual contributions toward the AA and DHA age-related distributions may be possible. The universal reduction in these LCPUFA in the first weeks of life (Figs. 1  and 2 ) possibly represents the cumulative effects of both dilution through tissue growth and maturation and some degree of mobilization from the adipose and endogenous hepatic stores. Easier to delineate could be that of dietary input, which during our study was confined to those infants receiving human milk and may be reflected in the differences between the corresponding group curves (Figs. 1 and 2) .
The contributions to liver AA and DHA contents provided by enzymatic desaturation and elongation of the essential fatty acids would in normal circumstances be the most difficult to differentiate. However, even with what appears a wholly inadequate provision of a-linolenic acid precursor in the third diet, it was observed that both formula group curves for DHA were virtually superimposable during the first 3 mo of life (Fig. 2) . This may indicate an absence or reduced supply of synthetic DHA to the infants in these formula groups. Subsequently there appears to be evidence of a relative increase in the hepatic DHA of group 2 compared with group 3 (Fig. 2) . It may be that only after approximately 12 wk is optimal hepatic synthesis of DHA evinced and that irrespective of dietary provision of a-linolenic acid, A4-desaturation is poorly or nonfunctioning in early life. This appears to corroborate recent observations on cord plasma fatty acids which seein to demonstrate that A4-desaturation and not A6 or A5 may be rate-limiting in the formation of hepatic DHA (22) . If as indicated A4-desaturation is achieved through microsomal chain elongation of docosapentaenoic acid [C22:5(n-3)] followed by A6-desaturation then the final peroxisomal @-oxidation may be the true rate-limiting step to DHA production in the infant liver (21) . This has profound consequences for the supply of essential fatty acids and their LCPUFA derivatives to infants in the immediate postnatal period when brain growth and development are most vulnerable to reduced provision of these fatty acids. As we have now established that subcutaneous tissue reserves are insufficient (2) and hepatic A4-desaturation probably at best suboptimal, we again emphasize the need of dietary DHA for all formula-fed infants. It would appear that from the fourth month onward some conversion of a-linolenic acid to DHA occurs when the substrate is present in sufficient concentration such that synthetic DHA may represent approximately 0.6 glkg tissue in the liver at 5 mo (Fig. 2) . Within the human milk-fed group DHA results, that of the 16-wk-old infant at first appeared to be an outlier until it was recognized that uniquely this infant exhibited a subcutaneous tissue a-linolenic acid concentration similar to that of an SMA-fed infant (2). This hepatic DHA composition (Fig. 2) may correspond to the summation of both a dietary and synthetic component.
From Figure 1 the age-related distributions of M can be seen. However, the minimum levels, which as with DHA occur simultaneously at 8-10 wk in both formula-fed groups, repre-
